There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Prevail Therapeutics
Tag: NASDAQ:PRVL
Wedbush Sticks to Its Buy Rating for Prevail Therapeutics Inc (PRVL)
In a report released yesterday, Laura Chico from Wedbush reiterated a Buy rating on Prevail Therapeutics Inc (PRVL – Research